• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/18

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

18 Cards in this Set

  • Front
  • Back
Why do the lungs have low pressure in normal pulmonary circulation?
Vasodilators>>>Vasoconstrictors

Allows recruitment of under-perfused vessels
Distention of thin-walled vessels
Resistance is inversely proportional to _________.
Radius^4
What is the most important determinant of pulmonary vascular resistance?
Arterial lumen area (RADIUS)
Causes of Pulmonary Arterial Hypertension
Idiopathic
Heritable
Drug, Toxin (Fen Fen)

Assocd w/CT Dz, Congenital Heart Dz, HIV, Schistosomiasis
Pathophysiologic cause of pulmonary hypertension.
Vasoconstrictors (Thromboxane A2, Endothelin, Angiotensin II) >> Vasodilators (Prostacyclin NO, ANP, Symp Tone)
Changes involves in pulmonary vascular remodeling.
Intimal thickening
Medial smooth muscle hypertrophy
Adventitial thickening
Thromboses
Plexiform lesions

Note: all parts of arterial wall affected
Physical exam findings in pulmonary arterial hypertension.
Loud P2
RV Heave
TRICUSPID MURMUR
Peripheral EDEMA
Hallmark hemodynamic signs of pulmonary arterial hypertension.
Severely increased PA pressure and Pulm Vasc Resistance
Genetic cause of familial PAH
BMPR2 mutation (bone morphogenetic protein receptor II)
Treatment of Pulmonary Arterial Hypertension
Anticoag (PAH can cause thromboses)
O2 for hypoxia
Diuretics, digoxin x R-HF
Pulm vasodilators
Epoprostenol:
MOA
Use
Pulmonary vasodilator (but can act systemically)
Pulm CAD
Role of endothelin in PAH.
Endothelin binds SM to induce vasoconstriction

Inc'd endothelin expression in PAH
Why is sildenafil used in PAH?
NO induces cGMP broken down by PDE-5

Block PDE-5 with sildenafil to induce vasodilation
Bosentan:
MOA
Use
Blocks endothelin binding
PAH
Causes of pulmonary hypertension in patients with COPD.
Alveolar hypoxia-->vasoconstriction

Enhanced by respiratory acidosis (lower pH-->higher PVR)

Chronic hypoxia-->vasc remodeling

Loss of blood vessels

Hyperinflation-->mechanical compression of arteries

Polycythemia-->Inc blood viscosity
When does thromboembolism result in pulmonary hypertension? Why?
Recurrent or unresolved thromboemboli result in vascular remodeling and obstruction of vessels
Pulmonary Thromboembolism:
Treatment
Anticoag
Surgical removal of unresolved clot
How does cor pulmonale arise in pulmonary hypertension?
Pulm HTN-->Inc'd RV afterload-->RV HTN-->RV Dilation/failure